methyl 3-((acetylthio)methyl)benzoate | 1382034-00-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 3-((acetylthio)methyl)benzoate
• 英文别名: methyl 3-(acetylsulfanylmethyl)benzoate
• CAS: 1382034-00-5
• 化学式: C₁₁H₁₂O₃S
• 分子量: 224.28
• InChiKey: WSDQIICLVVLHBC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  68.7
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 3-((acetylthio)methyl)benzoate 在 sodium hydroxide 、 3,3,3-膦三基三丙酸 作用下， 以 1,4-二氧六环 、 水 为溶剂， 反应 1.25h， 以46%的产率得到3-(mercaptomethyl)-benzoic acid
  参考文献：
  名称：

  Design, Synthesis, and Pharmacological Evaluation of Glutamate Carboxypeptidase II (GCPII) Inhibitors Based on Thioalkylbenzoic Acid Scaffolds

  摘要：

  A series of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors have been synthesized with either a 3-(mercaptomethyl)benzoic acid or 2-(2-mercaptoethyl)benzoic acid scaffold. Potent inhibitors were identified from each of the two scaffolds with IC50 values in the single-digit nanomolar range, including 2-(3-carboxybenzyloxy)-5-(mercaptomethyl)benzoic acid 27c and 3-(2-mercaptoethyl)-biphenyl-2,3'-dicarboxylic acid 35c. Compound 35c was found to be metabolically stable and selective over a number of targets related to glutamate-mediated neurotransmission. Furthermore, compound 35c was found to be orally available in rats and exhibited efficacy in an animal model of neuropathic pain following oral administration.

  DOI：

  10.1021/jm300488m
• 作为产物：
  描述：

  3-(溴甲基)苯甲酸甲酯 、 potassium thioacetate 以 丙酮 为溶剂， 反应 1.5h， 以66%的产率得到methyl 3-((acetylthio)methyl)benzoate
  参考文献：
  名称：

  Design, Synthesis, and Pharmacological Evaluation of Glutamate Carboxypeptidase II (GCPII) Inhibitors Based on Thioalkylbenzoic Acid Scaffolds

  摘要：

  A series of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors have been synthesized with either a 3-(mercaptomethyl)benzoic acid or 2-(2-mercaptoethyl)benzoic acid scaffold. Potent inhibitors were identified from each of the two scaffolds with IC50 values in the single-digit nanomolar range, including 2-(3-carboxybenzyloxy)-5-(mercaptomethyl)benzoic acid 27c and 3-(2-mercaptoethyl)-biphenyl-2,3'-dicarboxylic acid 35c. Compound 35c was found to be metabolically stable and selective over a number of targets related to glutamate-mediated neurotransmission. Furthermore, compound 35c was found to be orally available in rats and exhibited efficacy in an animal model of neuropathic pain following oral administration.

  DOI：

  10.1021/jm300488m

文献信息

• Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state
  作者：Matthijs J. van Haren、Rebecca Taig、Jilles Kuppens、Javier Sastre Toraño、Ed E. Moret、Richard B. Parsons、Davide Sartini、Monica Emanuelli、Nathaniel I. Martin

  DOI：10.1039/c7ob01357d

  日期：——

  inhibitors derived from the structures of the substrates involved in the methylation reaction. By covalently linking fragments of the NNMT substrates a diverse library of bisubstrate-like compounds was prepared. The ability of these compounds to inhibit NNMT was evaluated providing valuable insights into the structural tolerances of the enzyme active site. These studies led to the identification of new

  烟酰胺N-甲基转移酶（NNMT）是一种催化烟酰胺甲基化以形成N的酶′-甲基烟酰胺。NNMT及其甲基化产物最近都与多种疾病有关，这表明该酶作为其治疗目标的作用已超出其先前在排毒中赋予的代谢功能。我们在这里描述了来自参与甲基化反应的底物结构的NNMT抑制剂的系统开发。通过共价连接NNMT底物的片段，制备了多种双底物样化合物库。评估了这些化合物抑制NNMT的能力，为了解酶活性位点的结构耐受性提供了宝贵的见识。